Report: Digital Health Funding Witnesses USD 1.4 Billion In First Quarter Of 2019

Healthcare News

Report_Digital-Health-Funding-Witnesses-USD-1.4-Billion-In-First-Quarter-Of-2019 Report: Digital Health Funding Witnesses USD 1.4 Billion In First Quarter Of 2019Digital health is the convergence of the Digital and Genomic Revolutions with healthcare, health, living, and society. It’s empowering people to better track, manage, and improve their own and their family’s health, live better, more productive lives, then after ultimately improve society. As an outgrowth of the Digital Revolution by the mass production and extensive use of digital logic circuits, and its derived technologies, like the computer, digital cellular phone, and the Internet, digital health comprises key elements are wireless devices, hardware sensors, and software sensing technologies,  the Internet, social networking, mobile/cellular networks, and body area networks, microprocessors and integrated circuits, health information technology, genomics, and personal genetic information.

Beginning of the year, MobiHealthNews, a healthtech publication platform, has found out that in Q1 funding of USD 1.4 billion this year spread out more than 49 companies. The number of companies this year increased from last year’s Q1 funding that came in at USD 1.2 billion. Moreover, Rock Health, a full-service seed fund company, issued its funding report for the quarter racking USD986 million of investments across 61 deals in the US. In the meantime, Startup Health reported USD 2.8 billion in funding last quarter. The MobiHealthNews’ report further noted a list of the funding announcement by the company, including Clover Health, a San Francisco-based healthcare company that raised USD500 million from Greenoks Capital and will be utilized for growth, innovation and deepening ties with physicians.

As part of the development, Doctolib, an online and mobile booking platform, raised USD 170.30 million, which is led by General Atlantic, Eurazeo, Bpifrance, Kernel, Accel and unnamed German healthcare entrepreneurs. The fresh capital, according to the company, will be used to stimulate growth in France and Germany, in addition, to push into other international marketplaces. Besides, it will also utilize funds for product development and to foster its telehealth offering that introduced last month.